𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Development and resolution of colitis in mice with target deletion of dipeptidyl peptidase IV

✍ Scribed by Dijana Detel; Ester Pernjak Pugel; Lara Baticic Pucar; Suncica Buljevic; Jadranka Varljen

Book ID
119880658
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
804 KB
Volume
97
Category
Article
ISSN
0958-0670

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Development and resolution of experiment
Development and resolution of experimental colitis in mice with targeted deletion of dipeptidyl peptidase IV
✍ Mark S. Geier; Danik Tenikoff; Roger Yazbeck; Geoffrey W. McCaughan; Catherine A πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 111 KB

## Abstract Glucagon‐like peptide‐2 (GLP‐2) is a potent intestinotrophic growth factor that enhances repair of damaged intestinal tissue. However, its bioactivity is limited by dipeptidyl peptidase IV (DPIV)‐mediated degradation. We hypothesized that DPIV^βˆ’/βˆ’^ mice would display an increased resist

Neuroimmunomodulative properties of dipe
Neuroimmunomodulative properties of dipeptidyl peptidase IV/CD26 in a TNBS-induced model of colitis in mice
✍ Lara Baticic; Dijana Detel; Natalia Kucic; Suncica Buljevic; Ester Pernjak Pugel πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 449 KB

## Abstract Causal connections between dipeptidyl peptidase IV, also known as CD26 molecule (DPP IV/CD26) and inflammatory bowel disease (IBD) have been shown, but mechanisms of these interactions are unclear. Our hypothesis was that DPP IV/CD26 could affect the neuroimmune response during inflamma